Literature DB >> 20849899

Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy.

Takafumi Hasegawa1, Toru Baba, Michiko Kobayashi, Masatoshi Konno, Naoto Sugeno, Akio Kikuchi, Yasuto Itoyama, Atsushi Takeda.   

Abstract

Multiple system atrophy (MSA) is a progressive neurodegenerative disorder presenting variable combinations of parkinsonism, cerebellar ataxia, corticospinal and autonomic dysfunction. Alpha-synuclein (α-SYN)-immunopositive glial cytoplasmic inclusions (GCIs) represent the neuropathological hallmark of MSA, and tubulin polymerization promoting protein (TPPP)/p25 in oligodendroglia has been known as a potent stimulator of α-SYN aggregation. To gain insight into the molecular pathomechanisms of GCI formation and subsequent oligodendroglial degeneration, we ectopically expressed α-SYN and TPPP in HEK293T and oligodendroglial KG1C cell lines. Here we showed that TPPP specifically accelerated α-SYN oligomer formation and co-immunoprecipitation analysis revealed the specific interaction of TPPP and α-SYN. Moreover, phosphorylation of α-SYN at Ser-129 facilitated the TPPP-mediated α-SYN oligomerization. TPPP facilitated α-SYN-positive cytoplasmic perinuclear inclusions mimicking GCI in both cell lines; however, apoptotic cell death was only observed in KG1C cells. This apoptotic cell death was partly rescued by sirtuin 2 (SIRT2) inhibition. Together, our results provide further insight into the molecular pathogenesis of MSA and potential therapeutic approaches.
Copyright © 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20849899     DOI: 10.1016/j.neuint.2010.09.002

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  23 in total

Review 1.  Multiple system atrophy: a clinical and neuropathological perspective.

Authors:  Kiren Ubhi; Phillip Low; Eliezer Masliah
Journal:  Trends Neurosci       Date:  2011-09-29       Impact factor: 13.837

Review 2.  Novel therapeutic approaches in multiple system atrophy.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2014-06-14       Impact factor: 4.435

Review 3.  The neuropathology of multiple system atrophy and its therapeutic implications.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Auton Neurosci       Date:  2017-11-10       Impact factor: 3.145

Review 4.  Oligodendroglia and neurotrophic factors in neurodegeneration.

Authors:  Andrew N Bankston; Mariana D Mandler; Yue Feng
Journal:  Neurosci Bull       Date:  2013-04-05       Impact factor: 5.203

Review 5.  Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins.

Authors:  George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-10-02       Impact factor: 5.590

6.  Mitochondrial Metabolism Power SIRT2-Dependent Deficient Traffic Causing Alzheimer's-Disease Related Pathology.

Authors:  D F Silva; A R Esteves; C R Oliveira; S M Cardoso
Journal:  Mol Neurobiol       Date:  2016-06-17       Impact factor: 5.590

Review 7.  New insights into atypical parkinsonism.

Authors:  Gregor K Wenning; Florian Krismer; Werner Poewe
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

8.  Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy.

Authors:  Masatoshi Konno; Takafumi Hasegawa; Toru Baba; Emiko Miura; Naoto Sugeno; Akio Kikuchi; Fabienne C Fiesel; Tsutomu Sasaki; Masashi Aoki; Yasuto Itoyama; Atsushi Takeda
Journal:  Mol Neurodegener       Date:  2012-08-14       Impact factor: 14.195

Review 9.  Multiple system atrophy: the application of genetics in understanding etiology.

Authors:  Monica Federoff; Lucia V Schottlaender; Henry Houlden; Andrew Singleton
Journal:  Clin Auton Res       Date:  2015-02-17       Impact factor: 4.435

Review 10.  Current Management and Emerging Therapies in Multiple System Atrophy.

Authors:  Matthew R Burns; Nikolaus R McFarland
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 6.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.